Skip to main content

$0.080 -0.005 (-5.88%)

High

$0.08

Low

$0.08

Trades

3

Turnover

$5,284

Volume

65,268
30 June 2023 at 10:32am
Register to track OIL and receive email alerts.

OIL breast cancer study to commence next stage - revised

StockBot

416,823 posts

OIL released this announcement to the ASX on 8 February 2021, 15:02. The announcement is marked as price sensitive, and is 2 page(s) in length and 199.92kb in size.

You can view all announcements from OIL and see how they appear on a price chart on the announcements page.

At the date of this announcement, OIL was 0.001% short sold according to ASIC data. It was ranked the 675th most shorted stock on the ASX. It is now ranked as the 594th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (01 December 2025).

Other Recent Announcements from OIL
Update - Proposed issue of securities - OIL 26 June 2023, 11:18
Entitlement Offer Extension to Closing Date 26 June 2023, 11:13
Entitlement Offer - Letter to Ineligible Shareholders 7 June 2023, 11:37
OIL breast cancer study to commence next stage - revised 8 February 2021, 15:02
Optiscan breast cancer study to commence next stage 8 February 2021, 11:48
Section 708A Cleansing Notice and Appendix 2A 1 February 2021, 17:45
OIL December 2020 Quarterly Report and Appendix 4C 29 January 2021, 9:39
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track OIL and receive email alerts.